Biosynthetic musk & aromas

01Overview and value chain

Markers: [EC: REACH chemical registration (EC 1907/2006, incl. nitro-musk/polycyclic-musk restrictions) + China API/drug manufacturing licensing (NMPA) for TCM artificial-musk substitutes | OECD: Industrial biotechnology | Regulator: REACH (EU), NMPA (China)]

Musk is the fixative and sensual base note of fine perfumery, historically sourced from musk-deer glands (now restricted for animal-welfare and conservation reasons) or from nitro-musk and polycyclic-musk chemistry, both of which face REACH restrictions in the EU over environmental persistence and bioaccumulation. In 2026 the confirmed commercial activity centers on established macrocyclic ketone and lactone chemistries rather than a dedicated engineered-yeast fermentation product: Givaudan markets Velvione, a 16-membered macrocyclic musk ketone described in trade literature as carrying a warm, powdery, animalic note; DSM-Firmenich continues its Exaltolide brand, a macrocyclic-lactone musk dating to Firmenich’s classic perfumery-materials portfolio; IFF unveiled its Orionide Oliffac clean-musk line at SIMPPAR 2026, positioned as a “modern clean musk” with a soft, natural-leaning, low-weight diffusion profile; and in China, Beijing Lianxin Pharmaceutical (founded 1999, co-established by the Institute of Materia Medica of the Chinese Academy of Medical Sciences and three other state-linked shareholders) manufactures a state-designated Class-1 new-drug “artificial musk” substitute for musk-deer secretions used in traditional-medicine formulations, recognized with a National Science and Technology Progress Award. A dedicated engineered-yeast fermentation route to macrocyclic musks — omega-hydroxy fatty-acid production via oleaginous yeast followed by lipase-catalyzed macrocyclization — appears in patent-application literature (“biotechnological production of macrocyclic lactones,” filed 2022, published 2026) but no confirmed commercial company was identified as its assignee or commercial operator in 2026 sourcing.

The key directions of biosynthetic musk & aromas are:

1. Macrocyclic musk ketone production (Macrocyclic Musk Ketone Production): Givaudan’s Velvione, a 16-membered macrocyclic musk ketone marketed as a modern, non-nitro alternative carrying an animalic-powdery character.
2. Established macrocyclic lactone branding (Macrocyclic Lactone Musk Branding): DSM-Firmenich’s Exaltolide, a long-standing macrocyclic-lactone musk brand from Firmenich’s classic perfumery-materials heritage.
3. Clean-musk reformulation (Clean Musk Fragrance Formulation): IFF’s Orionide Oliffac, unveiled at SIMPPAR 2026, positioned as a soft, natural-leaning musk with enhanced diffusion and substantivity without added olfactive weight.
4. TCM artificial-musk substitute manufacturing (TCM Artificial Musk Substitute Manufacturing): Beijing Lianxin Pharmaceutical’s state-designated Class-1 new-drug artificial musk, replacing endangered musk-deer secretions in traditional-medicine formulations under NMPA oversight.

Sectoral value chain

[macrocyclic ketone/lactone precursors or musk-deer-secretion-analog chemistry] ──> [chemical macrocyclization or multi-component synthesis]
                                                                                                │
                                                                                (crude musk material)
                                                                                                │
                                                                                                ▼
[fine-perfumery or pharmaceutical-grade musk] <─── [purification and olfactive/pharmacopeial QC] <───┘
                                                                                                │
                                                                                                ▼
                                                [fine perfumery, personal care, traditional-medicine formulations]

Value chain levels

Cross-cutting technologies of the sector:

• Macrocyclic ring chemistry (Macrocyclic Musk Ketone Production / Macrocyclic Lactone Musk Branding): the 15-17-membered ring structures (Velvione’s 16-membered ketone, Exaltolide’s macrocyclic lactone) shared by the dominant non-nitro musk chemistries.
• Clean-label reformulation (Clean Musk Fragrance Formulation): IFF’s Orionide Oliffac positioning around a “natural-leaning,” low-weight olfactive profile, reflecting the sector-wide move away from nitro- and polycyclic-musk restricted chemistries.
• State-designated substitute drug manufacturing (TCM Artificial Musk Substitute Manufacturing): Beijing Lianxin’s NMPA-certified Class-1 new-drug status for artificial musk, a distinct regulatory and technical pathway from fragrance-grade musk chemistry.

02US

The US role in this Industry is a single confirmed 2026 commercial launch — IFF’s Orionide Oliffac clean-musk line — rather than a dedicated engineered-yeast fermentation platform; broader US industrial-biotechnology yeast/terpenoid work did not confirm a musk-specific commercial product in this search round.

IFF, Orionide Oliffac, SIMPPAR 2026

• IFF (International Flavors & Fragrances, United States): unveiled Orionide Oliffac at SIMPPAR 2026, described in the company’s own announcement as “a modern clean musk with a soft, creamy signature and a natural-leaning profile,” with subtle floral and delicate animalic accents that enhance diffusion and substantivity without adding olfactive weight.
• Research gap: other US industrial-biotechnology platform companies active in yeast/terpenoid metabolic engineering did not return a musk-specific commercial confirmation in this search round; the engineered-yeast macrocyclic-lactone route described in early research literature remains unconfirmed against a named US commercial operator.

03CN

China’s confirmed 2026 activity is concentrated in pharmaceutical-grade artificial-musk substitute manufacturing for traditional-medicine use rather than fragrance-grade macrocyclic musk production.

Beijing Lianxin Pharmaceutical, NMPA Class-1 artificial musk

• Beijing Lianxin Pharmaceutical (Beijing, China): founded 1999 by the Institute of Materia Medica of the Chinese Academy of Medical Sciences alongside Shandong Hongjitang Pharmaceutical Group, Shanghai Yaocai and China TCM Co.; manufactures a state-designated Class-1 new-drug “artificial musk” (人工麝香) substitute for musk-deer secretions used in traditional-medicine formulations, GMP- and ISO 9001-certified, and recognized with a National Science and Technology Progress Award for the underlying substitution technology.
• Research gap: no fragrance-grade macrocyclic-musk commercial originator using engineered-yeast fermentation of soybean-oil-derived fatty acids was confirmed in Chinese sourcing, despite this being the specific route described in early research literature; confirmed Chinese “artificial musk” activity is instead concentrated in the pharmaceutical/TCM substitute segment.
• Regulatory pathway: artificial musk manufactured as a TCM drug substance requires NMPA Class-1 new-drug certification, distinct from the REACH chemical-registration pathway used for fragrance-grade musk placed on Western markets.

04EU

The EU anchors the dominant commercial macrocyclic musk brands — Givaudan and DSM-Firmenich, both Swiss flavors-and-fragrances majors — under the REACH chemical-registration regime that has progressively restricted nitro- and polycyclic-musk chemistries on environmental-persistence grounds.

Givaudan, DSM-Firmenich, REACH

• Givaudan (Switzerland): markets Velvione, a 16-membered macrocyclic musk ketone described in perfumery trade literature as carrying “the warm, powdery, faintly animalic whisper” associated with legacy nitro-musks but without their environmental-persistence profile.
• DSM-Firmenich (Switzerland): continues the Exaltolide brand, a macrocyclic-lactone musk from Firmenich’s classic perfumery-materials heritage, marketed as a top-note musk ingredient across fine-fragrance and personal-care formulations.
• REACH & restriction framework: musk ingredients placed on the EU market fall under REACH chemical registration, evaluation and authorisation; nitro-musks (e.g. musk ketone/musk xylene classes) and several polycyclic musks face specific REACH restrictions on environmental-persistence and bioaccumulation grounds, a key driver of the sector’s shift toward macrocyclic ketone/lactone chemistries.

05Leading companies and research institutes

06Tech stack and innovations

The stack spans established macrocyclic ring chemistry for fragrance-grade musk and a distinct pharmaceutical-substitute chemistry for traditional-medicine use, rather than a dedicated fermentation platform.

1. Macrocyclic ketone/lactone ring chemistry (Macrocyclic Musk Ketone Production / Macrocyclic Lactone Musk Branding):
   • Givaudan’s Velvione is built on a 16-membered macrocyclic ketone ring, positioned as a modern successor to legacy nitro-musks without their environmental-persistence liabilities.
   • DSM-Firmenich’s Exaltolide is a macrocyclic-lactone musk from the same broad chemistry family, differentiated by ring size and functional group (lactone vs. ketone).
2. Clean-label olfactive reformulation (Clean Musk Fragrance Formulation):
   • IFF’s Orionide Oliffac, unveiled at SIMPPAR 2026, is positioned around enhanced diffusion and substantivity “without adding weight,” reflecting a sector-wide push toward natural-leaning, low-intensity musk profiles.
3. State-designated substitute drug technology (TCM Artificial Musk Substitute Manufacturing):
   • Beijing Lianxin’s artificial-musk substitution technology replicates the composition of natural musk-deer secretions for traditional-medicine formulations, certified as a Class-1 new drug and recognized with a National Science and Technology Progress Award — a technically and regulatorily distinct achievement from fragrance-grade macrocyclic musk chemistry.
   • A separate engineered-yeast route (omega-oxidation of fatty acids via oleaginous yeast, followed by lipase-catalyzed macrocyclization) appears in patent-application literature filed 2022 and published 2026, but remains unconfirmed against a named commercial operator.

07Value chains and production pipelines

Industrial pipeline of biosynthetic musk & aromas (REACH / NMPA Class-1)

┌───────────────────────────┐      ┌───────────────────────────┐
│ 1. Feedstock sourcing     │ ───> │ 2. Synthesis               │
│    (precursor chemicals)  │      │    (macrocyclization or    │
│                            │      │    multi-component)        │
└───────────────────────────┘      └───────────────────────────┘
                                                   │
                                                   ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 4. Regulatory              │ <─── │ 3. Purification / QC      │
│    certification            │      │                            │
└───────────────────────────┘      └───────────────────────────┘
              │
              ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 5. Formulation & branding  │ ───> │ 6. End-use application    │
│    (REACH/NMPA grade)      │      │    (perfumery, TCM)       │
└───────────────────────────┘      └───────────────────────────┘

Stage 1: Feedstock sourcing

Macrocyclic ketone/lactone precursor chemicals feed Givaudan’s, DSM-Firmenich’s and IFF’s fragrance-grade musk synthesis; a defined multi-component chemical formulation replicating musk-deer secretion composition feeds Beijing Lianxin’s TCM-grade artificial-musk manufacturing.

Stage 2: Synthesis

Chemical macrocyclization (ring closure) produces macrocyclic musk ketones (Givaudan’s 16-membered Velvione ring) or lactones (DSM-Firmenich’s Exaltolide); IFF applies its own synthesis route for the Orionide Oliffac clean-musk line; Beijing Lianxin performs multi-component chemical synthesis to replicate natural musk-deer secretion composition.

Stage 3: Purification / QC

Fragrance-grade musk undergoes olfactive and analytical purification to meet perfumery-industry specification; Beijing Lianxin’s artificial musk undergoes pharmacopeial-grade purification and quality control as a certified drug substance.

Stage 4: Regulatory certification

Fragrance-grade musk placed on the EU market is certified under REACH chemical registration, evaluation and authorisation, with nitro- and several polycyclic-musk chemistries subject to specific environmental-persistence restrictions; Beijing Lianxin’s artificial musk carries NMPA Class-1 new-drug certification.

Stage 5: Formulation & branding

Certified musk material is blended into finished perfumery compositions under proprietary brand names — Givaudan’s Velvione, DSM-Firmenich’s Exaltolide, IFF’s Orionide Oliffac (unveiled at SIMPPAR 2026) — or formulated into traditional-medicine preparations by Beijing Lianxin.

Stage 6: End-use application

Finished musk ingredient is applied in fine perfumery and personal-care fragrance compositions across all three F&F majors’ customer bases, or in traditional-medicine formulations replacing endangered musk-deer secretions at Beijing Lianxin.